港股異動 | 平安好醫生(1833.HK)急升至6% 線上醫療服務收入強勁增長
格隆匯2月6日丨平安好醫生(1833.HK)高開後急升至5.95%,報73.95港元,暫成交1.89億港元,最新總市值778.59億港元。新型肺炎疫情持續發展,平安好醫生就發揮出其醫療健康生態平台的重大作用,為民眾提供及時專業的在線問診服務,成為全國線下醫療資源的重要補充,共同抗擊病毒。數據顯示,近期在線醫療平台輕問診服務上線24小時,累計訪問用户數近40萬。線上醫療平台均迎來訪問峯值。大和日前發研報指,認為內地爆發新型冠狀病毒將使大眾瞭解線上醫療服務,估計其線上醫療服務收入增長勢頭強勁情況在2019及2020年能維持。此外,平安好醫生將於本月11日披露年度業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.